From valorinternational · · 1m
Ourofino targets South American markets
Ourofino plans to expand animal health sales in Argentina, Uruguay and Paraguay by 2030.
In brief
Ourofino plans to expand animal health sales in Argentina, Uruguay and Paraguay by 2030. Ourofino, Brazil's largest veterinary pharmaceutical company, aims to become a market leader in Argentina, Uruguay and Paraguay by 2030 through antiparasitic products. Originally reported by valorinternational.
Ourofino expansion plan
Ourofino, Brazil’s largest veterinary pharmaceutical company, targets stronger presence in South America.
International revenue growth
The company generated 11% of its net revenue from international operations in the first half.
Argentina and Uruguay focus
/https://i.s3.glbimg.com/v1/AUTH_37554604729d4b2f9f3eb9ad8a691345/internal_photos/bs/2026/x/j/aED8bBRrSIT2fK7mObbQ/foto05agr-101-ouro-b11.jpg)
Ourofino plans to enter Argentina and Uruguay with marketing, sales and technical support.
Paraguay expansion
Ourofino aims to strengthen its presence in Paraguay by 2030 through local partner negotiations.
Antiparasitic products
Ourofino will focus on antiparasitic products for cattle herds in Argentina and Uruguay.
Market leadership goal
/i.s3.glbimg.com/v1/AUTH_37554604729d4b2f9f3eb9ad8a691345/internal_photos/bs/2026/x/j/aED8bBRrSIT2fK7mObbQ/foto05agr-101-ouro-b11.jpg)
CEO Kleber Gomes aims to become a market leader in Argentina, Uruguay and Paraguay by 2030.
What to remember
Ourofino, Brazil's largest veterinary pharmaceutical company, aims to become a market leader in Argentina, Uruguay and Paraguay by 2030 through antiparasitic products.
/https://i.s3.glbimg.com/v1/AUTH_37554604729d4b2f9f3eb9ad8a691345/internal_photos/bs/2026/w/O/ABtK3MTuWAEu3e3AjBeA/foto04emp-201-loro-b6.jpg)
